Literature DB >> 420859

Comparison of type I hexokinases from pig heart and kinetic evaluation of the effects of inhibitors.

D T Vowles, J S Easterby.   

Abstract

Type I hexokinase (ATP:D-hexose 6-phospotransferase, EC 2.7.1.1) of porcine heart exists in two chromatographically distinct forms. These do not differ significantly in size, electrophoretic mobility at pH 8.6 or kinetic properties. Both forms obey a sequential mechanism and are potently inhibited by glucose 6-phosphate. In contrast to observations of type I hexokinase from brain, inhibition by glucose 6-phosphate is not relieved by inorganic phosphate. Under most conditions, low concentrations of phosphate (less than 10 mM) have little effect on the kinetic behaviour of the enzyme but at higher concentrations this ligand is an inhibitor. Mannose 6-phosphate inhibits in a manner analogous to glucose 6-phosphate but the Ki is much greater. In view of the similarity of the kinetic parameters governing phosphorylation of mannose and glucose, this difference in affinity for the inhibitor site is seen as consistent with the existence of a separate regulatory site on the enzyme. MgADP inhibits hexokinase but behaves as a normal product inhibitor and inhibition is competitive with respect to MgATP and non-competitive with respect to glucose.

Entities:  

Mesh:

Substances:

Year:  1979        PMID: 420859     DOI: 10.1016/0005-2744(79)90032-9

Source DB:  PubMed          Journal:  Biochim Biophys Acta        ISSN: 0006-3002


  5 in total

1.  Kinetic properties of hexokinase as assembled with a microcomputer data base.

Authors:  L Garfinkel; D Garfinkel; P Matsiras; B Matschinsky
Journal:  Biochem J       Date:  1987-06-01       Impact factor: 3.857

2.  Modified properties of hexokinase from heart mitochondria prepared using proteolytic enzyme.

Authors:  E Aubert-Foucher; B Font; D C Gautheron
Journal:  Mol Cell Biochem       Date:  1985-07       Impact factor: 3.396

3.  Different properties of the mitochondrial and cytosolic hexokinases in maize roots.

Authors:  A Galina; M Reis; M C Albuquerque; A G Puyou; M T Puyou; L de Meis
Journal:  Biochem J       Date:  1995-07-01       Impact factor: 3.857

4.  Microheterogeneity of cytosolic and membrane-bound hexokinase II in Morris hepatoma 3924A.

Authors:  A Rempel; P Bannasch; D Mayer
Journal:  Biochem J       Date:  1994-10-01       Impact factor: 3.857

5.  Molecular forms of red blood cell hexokinase.

Authors:  G Fornaini; M Dachà; M Magnani; V Stocchi
Journal:  Mol Cell Biochem       Date:  1982-12-10       Impact factor: 3.396

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.